Adamis Pharmaceuticals | ADMP - Action



Action Changement Date
Adma Biologics USD 222.1M 15.63M 2026-03
Cara Therapeutics USD 900K 0 2025-03
Cipla INR 61.6B 5.18B 2025-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.12B 46M 2025-09
Grifols EUR 3.56B 63.19M 2024-12
Merck USD 6.48B 179M 2026-03
Pfizer USD 10.67B 13M 2026-03
RedHill Biopharma USD 3.17M 482K 2025-06